96 related articles for article (PubMed ID: 7536653)
1. [Intracardial thrombus formation in heparin-associated thrombocytopenia type II].
Scheffold N; Greinacher A; Cyran J
Dtsch Med Wochenschr; 1995 Apr; 120(15):519-22. PubMed ID: 7536653
[TBL] [Abstract][Full Text] [Related]
2. Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.
Ronchard T; Salaun E; Theron A; Grisoli D; Jaussaud N; Collart F; Habib G; Camoin-Jau L
Ann Thorac Surg; 2017 Jan; 103(1):e9-e10. PubMed ID: 28007287
[TBL] [Abstract][Full Text] [Related]
3. Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
Kleinschmidt S; Seyfert UT
Angiology; 1995 Jan; 46(1):37-44. PubMed ID: 7818155
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid.
Sauer M; Gruhn B; Fuchs D; Altermann WW; Greinacher A; Völpel H; Zintl F
Med Pediatr Oncol; 1999 Jun; 32(6):457-8. PubMed ID: 10358710
[No Abstract] [Full Text] [Related]
5. [Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
Emig U; Meyer T; Buchwald AB
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):965-8. PubMed ID: 9280716
[TBL] [Abstract][Full Text] [Related]
6. Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts.
Klement D; Rammos S; v Kries R; Kirschke W; Kniemeyer HW; Greinacher A
Eur J Pediatr; 1996 Jan; 155(1):11-4. PubMed ID: 8750802
[TBL] [Abstract][Full Text] [Related]
7. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.
Koster A; Meyer O; Hausmann H; Kuppe H; Hetzer R; Mertzlufft F
J Clin Anesth; 2000 Jun; 12(4):324-7. PubMed ID: 10960207
[TBL] [Abstract][Full Text] [Related]
8. Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
Shapiro M; Cohen J; Inbal A; Singer P
Isr Med Assoc J; 2009 Mar; 11(3):188-90. PubMed ID: 19544713
[No Abstract] [Full Text] [Related]
9. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
Grassegger A; Fritsch P; Reider N
Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
[TBL] [Abstract][Full Text] [Related]
10. [Heparin-associated type II thrombocytopenia as a cause of multiple thromboembolism complications].
Scheffold N; Kuthan P; Cyran J
Vasa; 1996; 25(2):168-73. PubMed ID: 8659220
[TBL] [Abstract][Full Text] [Related]
11. [Late onset of heparin-induced thrombocytopenia with recurrent arterial thromboses and amputation].
Mörsdorf S; Pistorius G; Orthleb R; Pindur G; Schenk J
Dtsch Med Wochenschr; 1999 Oct; 124(43):1271-4. PubMed ID: 10587714
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
Greinacher A; Eckhardt T; Mussmann J; Mueller-Eckhardt C
Thromb Res; 1993 Jul; 71(2):123-6. PubMed ID: 7689764
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
Keeling DM; Richards EM; Baglin TP
Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
[TBL] [Abstract][Full Text] [Related]
14. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
[TBL] [Abstract][Full Text] [Related]
15. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Kikta MJ; Keller MP; Humphrey PW; Silver D
Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
[TBL] [Abstract][Full Text] [Related]
16. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
17. A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Masumoto H; Shimamoto M; Yamazaki F; Nakai M; Fujita S; Itonaga T; Nomura R
Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):365-7. PubMed ID: 17954999
[TBL] [Abstract][Full Text] [Related]
18. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
Gavranić BB; Basić-Jukić N; Kes P
Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
[TBL] [Abstract][Full Text] [Related]
19. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
[No Abstract] [Full Text] [Related]
20. [Heparin-induced thrombocytopenia as the cause of persistent bleeding after pacemaker implantation].
Madei W; Klieser HP; Hoerauf K
Dtsch Med Wochenschr; 1999 Apr; 124(16):487-90. PubMed ID: 10341752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
